We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. ...>>>You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
Show vendors
Medical Conditions
- COVID-19
- Monkeypox
- Essential Tremor
- Fusariosis
- Hypoxanthine Guanine Phosphoribosyltransferase Deficiency
- Myopathy, Central Core
- Nasal Obstruction
- Neurogenic Bowel
- Optic Disk Drusen
- Osteolysis
- Shock, Cardiogenic
- Spondylolysis
- Thrombocytosis
- Trisomy 13
- Uniparental Disomy of Chromosome 11
- View Full List
Sponsors and Collaborators
- Bio-Path Holdings, Inc.
- Biocool AB
- Boise State University
- Expression Therapeutics, LLC
- Fangshan Hospital of Traditional Chinese Medicine,
- General Hospital Sveti Duh
- ICOS Corporation
- Insmed Incorporated
- Intelomed, Inc.
- North Middlesex University Hospital NHS Trust
- People's Hospital of Zhengzhou University
- The General Hospital of Northern Theater Command
- Uniuversity of Genua, Italy
- View Full List
Drug Interventions
- ARRY-614, p38/Tie2 inhibitor; oral
- Bevasiranib
- Carbidopa-levodopa 25-100 mg
- Dexchlorpheniramine 1% lotion
- GSK163090
- Low molecular weight heparin
- MEM 1003
- MK0663, Etoricoxib / Duration of Treatment : 12 Weeks
- Ponatinib 15 MG
- Prostavasin
- RO5083945
- Ropivacaine Injection
- Tc 99m tilmanocept
- View Full List